Hai Long Yu | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Best Researcher Award

Hai Long Yu
Researcher Hai Long Yu
Affiliation Universiti Sains Malaysia
Country Malaysia
Scopus ID 58881245200
Documents 2
Citations 12
h-index 1
Subject Area Pharmacology
Event Global Scholar Awards
ORCID 0000-0002-2639-9780

Hai Long Yu
Universiti Sains Malaysia

Hai Long Yu is affiliated with Universiti Sains Malaysia and conducts research within the field of pharmacology. The available scholarly record indicates contributions emphasizing pharmaceutical science and related biomedical investigations. Through peer-reviewed publications indexed by Scopus, the researcher has established an emerging academic profile that demonstrates commitment to evidence-based research, scientific integrity, and interdisciplinary collaboration within modern pharmaceutical research environments.[1]

Abstract

Hai Long Yu has developed an emerging research profile in pharmacology through scholarly publications addressing pharmaceutical science, biomedical investigation, and evidence-based therapeutic research. The available literature demonstrates attention to scientific methodology, analytical rigor, and collaborative academic practices supporting advances in healthcare knowledge. Published work contributes to understanding pharmacological mechanisms and pharmaceutical applications while strengthening interdisciplinary scientific communication. Citation performance reflects growing recognition within the academic community. These contributions collectively illustrate sustained engagement with high-quality research activities and support professional consideration for academic recognition through the Best Researcher Award.[1][2]

Keywords

Pharmacology, pharmaceutical sciences, drug development, biomedical research, therapeutic compounds, molecular pharmacology, pharmaceutical analysis, experimental medicine, clinical translation, evidence-based therapeutics.

Introduction

Hai Long Yu conducts pharmacological research emphasizing scientific investigation, pharmaceutical innovation, and biomedical relevance. Current scholarly outputs demonstrate careful experimental methodology supporting improved understanding of therapeutic compounds, pharmaceutical applications, and healthcare advancement while contributing valuable knowledge through internationally indexed publications and collaborative academic research activities.[1]

Research Profile

Hai Long Yu maintains a developing scholarly profile at Universiti Sains Malaysia with publications indexed in Scopus. Research metrics demonstrate emerging academic influence supported by peer-reviewed outputs, measurable citation performance, interdisciplinary collaboration, and continuing participation in pharmaceutical research addressing scientifically significant biomedical questions.[1]

Research Contributions

Hai Long Yu contributes to pharmacological knowledge through research integrating experimental evaluation, pharmaceutical science, and biomedical interpretation. Published findings improve understanding of therapeutic mechanisms while encouraging scientific collaboration, reproducibility, and evidence-based decision making within pharmaceutical investigations and related healthcare research disciplines.[2]

Publications

Hai Long Yu has published peer-reviewed research indexed within Scopus, reflecting contributions to pharmacology and pharmaceutical science. Available publications demonstrate methodological consistency, scientific reporting standards, and collaborative investigation while supporting broader dissemination of biomedical knowledge through internationally recognized academic publishing platforms.[1][3]

Research Impact

Hai Long Yu demonstrates measurable scholarly impact through citations, peer-reviewed publications, and international indexing. Research visibility supports knowledge dissemination, encourages scientific collaboration, and provides foundational evidence benefiting pharmaceutical investigations while strengthening recognition within the broader pharmacology research community.[1]

Award Suitability

Hai Long Yu demonstrates qualities supporting consideration for the Best Researcher Award through emerging publication performance, scientific integrity, interdisciplinary collaboration, and measurable research visibility. Continued contributions to pharmacology align with recognition emphasizing innovation, academic excellence, and sustained commitment to evidence-based scientific advancement.[4]

Conclusion

Hai Long Yu continues developing an academic portfolio characterized by pharmacological research, peer-reviewed publications, and collaborative scientific inquiry. Available scholarly achievements demonstrate meaningful progress toward broader research influence while supporting continued professional recognition through international academic awards and future pharmaceutical research contributions.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Hai Long Yu, Author ID 58881245200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58881245200
  2. ORCID. (n.d.). Research profile of Hai Long Yu.
    https://orcid.org/0009-0008-0390-3308
  3. ResearchGate. (n.d.). Hai Long Yu research profile and scholarly outputs.
    https://www.researchgate.net/profile/Yu-Hai-Long
  4. Global Scholar Awards. (n.d.). Best Researcher Award Information.
    https://globalscholarawards.com/

Xiaoguang Huang | Pharmacology | Innovative Research Award

Published on by Global Scholar Awards

Innovative Research Award

Xiaoguang Huang
Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd, China

Xiaoguang Huang
Affiliation Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd
Country China
Scopus ID 57221178957
Documents 3
Citations 2
h-index 1
Subject Area Pharmacology
Event Global Scholar Awards
Scopus View Profile

Xiaoguang Huang is affiliated with Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd in China and contributes to research activities within Pharmacology. His academic profile demonstrates participation in scientific publications, citation visibility, and pharmaceutical research engagement. These scholarly activities support recognition within the Global Scholar Awards and reflect continued involvement in pharmacological and healthcare-related scientific advancement.[1]

Abstract

Xiaoguang Huang has contributed to pharmacological research through scholarly publications and scientific participation within pharmaceutical studies. His academic profile reflects publication visibility, citation activity, and engagement in healthcare-related scientific communication. The available research metrics demonstrate developing academic influence and commitment to pharmaceutical research advancement. His scholarly contributions support recognition within the Global Scholar Awards framework and indicate ongoing participation in evidence-based pharmacological investigations. The combination of publication records, institutional affiliation, and scientific engagement highlights his contribution to Pharmacology and supports broader academic dissemination within pharmaceutical and healthcare research communities internationally.[1]

Keywords

  • Pharmacology
  • Pharmaceutical Research
  • Drug Development
  • Healthcare Innovation
  • Scientific Publications
  • Global Scholar Awards

Introduction

Academic recognition within pharmaceutical sciences reflects research participation, scientific communication, and contribution to healthcare advancement. Xiaoguang Huang has engaged in Pharmacology research through publication activities and scholarly participation. His academic visibility and citation metrics support recognition within internationally focused pharmaceutical and scientific award programs.[1]

Research Profile

Xiaoguang Huang is affiliated with Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd in China and maintains scholarly visibility through Scopus-indexed publications and citation-based research metrics. His documented academic profile includes scientific publications, citation records, and measurable participation in pharmaceutical and healthcare-related scholarly communication activities.[1]

Research Contributions

His research contributions demonstrate engagement in pharmacological investigations and pharmaceutical research activities. Through scholarly publications and scientific participation, he has contributed to healthcare-related knowledge dissemination and academic communication. These efforts support broader scientific discussion and encourage continued advancement within pharmaceutical research communities internationally.[2]

Publications

The publication record associated with Xiaoguang Huang demonstrates participation in scientific dissemination and pharmacological research communication. His indexed academic outputs contribute to research accessibility, citation visibility, and institutional representation while supporting scholarly engagement through peer-reviewed scientific and pharmaceutical publication activities.[1]

Research Impact

Citation performance and publication visibility indicate measurable scholarly participation within pharmacological research. These academic indicators demonstrate engagement in scientific communication and healthcare knowledge development. The available research metrics reflect ongoing contribution to pharmaceutical scholarship and support recognition of continued academic involvement.[1]

Award Suitability

Xiaoguang Huang’s research profile, scholarly publications, and pharmaceutical research participation align with the objectives of the Global Scholar Awards. His academic visibility, citation activity, and scientific engagement demonstrate qualities associated with recognition programs focused on research excellence, healthcare advancement, and scholarly contribution.[3]

Conclusion

The academic activities of Xiaoguang Huang reflect scholarly participation within Pharmacology through scientific publications, citation visibility, and pharmaceutical research engagement. His developing research profile and institutional contributions support recognition within academic award frameworks dedicated to healthcare innovation, scientific communication, and pharmaceutical research advancement.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Xiaoguang Huang, Author ID 57221178957. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57221178957
  2. Global Scholar Awards. (n.d.). International academic recognition and research excellence program.
    Global Scholar Awards
  3. Huang, X., Zhang, A., Chen, D., Jia, Z., & Li, X. (2026). 4-Substituted 4-(1H-1,2,3-triazol-1-yl)piperidine: Novel C7 moieties of fluoroquinolones as antibacterial agents. SSRN Electronic Journal.
    https://pubmed.ncbi.nlm.nih.gov/20347299/

Mei Gao | Pharmacology | Research Excellence Award

Published on by Global Scholar Awards

Prof. Mei Gao | Pharmacology | Research Excellence Award

Professor | Chongqing General Hospital, Chongqing University | China

Prof. Mei Gao is a researcher affiliated with Stony Brook University, specializing in pharmacology, neuroscience, cancer research, and stem cell biology. With an outstanding record of 2,501 citations, an h-index of 27, and an i10-index of 41, she has made significant contributions to neuroprotection, ischemia-reperfusion injury, and molecular mechanisms underlying neurological and oncological diseases. Her highly cited work on compounds such as pinocembrin and luteolin has advanced understanding of apoptosis, oxidative stress, and neurovascular protection. Collaborating extensively with international research teams, her studies bridge basic and translational science. Her research holds strong societal impact by supporting the development of innovative therapeutic strategies and improving outcomes in neurological and cancer-related conditions.

Citation Metrics (Google Scholar)

2501
1800
1200
600
0

Citations

2501

h-index

27

i10-index

41

Citations

h-index

i10-index

View Scopus Profile
 View ORCID Profile
 View Google Scholar Profile

Featured Publications

Patrick Blin | Pharmacology | Research Excellence Award

Published on by Global Scholar Awards

Dr. Patrick Blin | Pharmacology | Research Excellence Award

University of Bordeaux | France

Dr. Patrick Blin is a distinguished researcher at Université de Bordeaux, recognized for his significant contributions to pharmacoepidemiology, clinical research, and real-world evidence studies. With an impressive record of 133 publications, 3,897 citations, and an h-index of 29, his work demonstrates substantial scientific impact and global recognition. His research focuses on drug safety, cardiovascular diseases, diabetes, and healthcare outcomes, often utilizing large-scale national healthcare databases. He has collaborated extensively with a wide network of international researchers, enhancing the interdisciplinary scope of his work. His studies contribute to improving clinical decision-making, optimizing therapeutic strategies, and advancing public health policies, thereby delivering meaningful societal and healthcare impact.

Citation Metrics (Scopus)

3897
3000
2000
1000
0

Citations

3897

Documents

133

h-index

29

Citations

Documents

h-index

View Scopus Profile View ORCID Profile View ResearchGate Profile

Featured Publications

Mahmoud Mansour | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Prof. Mahmoud Mansour | Pharmacology | Best Researcher Award

Professor | King Saud bin Abdulaziz University for Health Sciences | Saudi Arabia

Dr. Mahmoud Ahmed Mansour is a biomedical researcher affiliated with King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia, with recognized expertise in biochemical toxicology, oxidative stress, pharmacology, and cancer biology. His research primarily focuses on the molecular mechanisms of hepatocarcinogenesis, proteasome inhibition, antioxidant defense systems, and cardiometabolic complications. Dr. Mansour has authored 40 peer-reviewed publications, accumulating over 1,879 citations, with an h-index of 18, reflecting sustained scientific impact and scholarly influence. His highly cited works explore the antineoplastic potential of proteasome inhibitors such as carfilzomib, as well as oxidative stress in metabolic and reproductive health conditions. He has collaborated with more than 50 international co-authors, demonstrating strong interdisciplinary and cross-institutional engagement. The societal relevance of his research lies in advancing therapeutic strategies for cancer prevention, metabolic disorders, and drug-induced toxicity, contributing to improved clinical understanding and translational biomedical outcomes at a global level.

Citation Metrics (Scopus)

1879
1400
900
400
0

Citations

1,879

Documents

40

h-index

18

Citations

Documents

h-index

View Google Scholar Profile View Scopus Profile View ORCID Profile

Featured Publications

Lichun Zhao | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Prof. Dr. Lichun Zhao | Pharmacology | Best Researcher Award

Guizhou University of Traditional Chinese Medicine, China

Dr. Zhao Lichun is a highly accomplished researcher specializing in traditional Chinese medicine, trace elements, and health development. Currently serving as a postdoctoral fellow at Hong Kong Baptist University and doctoral supervisor at Guizhou University of Chinese Medicine, he has made significant contributions to advancing integrative medicine. He proposed the pioneering concept of “elemental traditional Chinese medicine” and identified rubidium as a key essential trace element for human health, shaping new perspectives in medical science. His career is distinguished by a strong record of innovation, leadership, and community engagement, reflected in more than 200 publications, numerous patents, and successful translation of research into certified medical products. Beyond his scientific work, Dr. Zhao plays an influential role in shaping academic development through editorial responsibilities, project evaluations, and leadership in professional organizations. With an outstanding academic profile and global collaborations, he continues to drive impactful research and nurture future scientific leaders.

Professional Profile 

Scopus Profile

Education

Dr. Zhao Lichun holds a Ph.D. in medical sciences with specialization in traditional Chinese medicine and trace element research. His doctoral training provided him with a solid foundation in advanced experimental methodologies, clinical translation, and interdisciplinary approaches that bridge medicine, chemistry, and biotechnology. Building on this expertise, he has pursued postdoctoral research at Hong Kong Baptist University, where he has expanded his international outlook and contributed to collaborative projects in health sciences. His academic journey reflects both depth and versatility, combining rigorous scientific inquiry with practical applications in drug discovery and product development. In addition to formal degrees, Dr. Zhao has continuously engaged in professional development through participation in academic training programs, international collaborations, and industry-focused initiatives. This blend of education and research experience has positioned him as a leading scholar capable of integrating traditional knowledge with modern scientific methods, thereby advancing the field of Chinese medicine and global healthcare.

Experience

Dr. Zhao Lichun’s professional experience spans academia, research leadership, and innovation-driven healthcare projects. At Guizhou University of Chinese Medicine, he serves as the Director of the Research Department and the Center for Trace Elements and Health Development, where he oversees scientific programs and mentors doctoral students. He also holds directorships at key laboratories in Guizhou and Guangxi, focusing on endangered medicinal material resources. His extensive project portfolio includes more than 30 national and international collaborations supported by the Ministry of Science and Technology of China and the National Natural Science Foundation of China. He has translated research into practice through the development of certified health products and clinical approval of innovative Chinese medicines, highlighting his capacity to merge academic excellence with real-world impact. In addition, his editorial leadership, project evaluation roles, and service in professional associations underscore his expertise in guiding research agendas, policy directions, and academic community building.

Research Interest

Dr. Zhao Lichun’s research interests lie at the intersection of traditional Chinese medicine, trace elements, and modern health sciences. He is especially recognized for introducing the concept of “elemental traditional Chinese medicine,” which explores the role of essential trace elements in human health and disease prevention. His pioneering work on rubidium as a critical trace element has opened new pathways for medical research and therapeutic development. Beyond elemental medicine, his interests encompass drug discovery, product development, and the integration of traditional knowledge with biotechnology and artificial intelligence for precision healthcare. He is also engaged in projects related to the conservation and utilization of endangered medicinal resources, bridging environmental sustainability with human health. By combining laboratory-based experimentation, clinical translation, and big data-driven approaches, Dr. Zhao aims to expand the scientific foundation of traditional Chinese medicine while contributing to global health innovation and interdisciplinary knowledge exchange.

Awards and Honors

Dr. Zhao Lichun has earned wide recognition for his scientific excellence and leadership, reflected in numerous prestigious awards and honors. He is the recipient of the National Youth Qihuang Scholar distinction, the Guangxi Youth Science and Technology Award, and has been recognized as an Outstanding Scholar in Guangxi. His leadership capabilities are further acknowledged through appointments such as Leader of High-Level Innovation Teams in Guangxi Higher Education Institutions and Academic and Technological Leader of Guangxi’s New Century talent programs. Additionally, he has received the Guangxi Science and Technology Progress Award, the Jilin Province Natural Science Award, and the China Industry-University-Research Cooperation Innovation Award, among others. Beyond individual achievements, he has been selected for Hong Kong’s “Excellent Talent Plan” and has contributed as an evaluation expert for major national projects and awards. These honors demonstrate his impactful contributions, sustained excellence, and influential role in advancing science and healthcare at both national and international levels.

Research Skills

Dr. Zhao Lichun possesses a diverse and advanced set of research skills spanning experimental science, translational medicine, and interdisciplinary collaboration. His expertise includes trace element analysis, molecular pharmacology, clinical research, and innovative drug development within the field of traditional Chinese medicine. He has strong capabilities in designing and managing large-scale research projects, demonstrated by his leadership of over 30 funded initiatives. His skills extend to scientific writing and dissemination, with more than 200 published papers and multiple edited monographs. He is adept at intellectual property management, evidenced by his extensive portfolio of patents and software copyrights, which translate laboratory findings into real-world applications. In addition, Dr. Zhao excels in academic leadership, editorial management, and evaluation of high-level research proposals. His ability to integrate advanced experimental methods with cross-disciplinary tools such as big data and artificial intelligence makes him a versatile researcher with both technical depth and strategic vision.

Publications Top Notes

Title: Bacteriostatic activity and mechanism of minerals containing rubidium
Journal: Science of Traditional Chinese Medicine
Year: 2025

Title: Traditional Chinese medicine in chronic rhinosinusitis: Mechanisms and postoperative recovery
Journal: Phytomedicine
Year: 2025
Citations: 3

Title: Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells
Journal: Naunyn-Schmiedeberg’s Archives of Pharmacology
Year: 2025
Citations: 13

Title: Interfacial Stabilization through MOF-Polymer Core-Shell Design: Ultraefficient, Stable and Recyclable Enzymatic Microreactors
Journal: ACS Applied Materials & Interfaces
Year: 2025

Title: Rubidium salt can effectively relieve the symptoms of DSS-induced ulcerative colitis
Journal: Biomedicine & Pharmacotherapy
Year: 2024
Citations: 22

Title: The close relationship between trace elements (Cu, Fe, Zn, Se, Rb, Si, Cr, and V) and Alzheimer’s disease: Research progress and insights
Year: 2025

Conclusion

Dr. Zhao Lichun’s outstanding record of scientific innovation, leadership in research, and service to the academic community makes him an exceptional candidate for the Best Researcher Award. His pioneering concepts in elemental traditional Chinese medicine, prolific publication and patent portfolio, leadership in multiple research organizations, and role in advancing international collaborations all underscore his suitability for this recognition. With his proven track record and strong potential for future breakthroughs, Dr. Zhao not only represents excellence in research but also embodies the qualities of a leader shaping the future of global science and healthcare.

Iram Iqbal | Cardiovascular Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Ms. Iram Iqbal | Cardiovascular Pharmacology | Best Researcher Award

PHD Scholar at Department of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, Pakistan

Dr. Iram Iqbal, a dedicated pharmacology researcher and academic, has made significant contributions to ethnopharmacology, pharmaceutical quality assurance, and drug development. With a Pharm.D., M.Phil., and ongoing Ph.D. from Bahauddin Zakariya University, her research explores the pharmacological potential of medicinal plants and modern drug delivery mechanisms. She has served in multiple professional roles, including as a Drug Analyst at the Primary & Secondary Healthcare Department and as a lecturer, demonstrating expertise in pharmaceutical instrumentation and quality control aligned with ISO 17025 standards. Dr. Iqbal has published extensively in peer-reviewed journals, contributed book chapters, and presented at numerous national and international conferences. Her technical proficiency with instruments such as HPLC, GC-MS, and FTIR, coupled with her strong communication and organizational skills, underscores her commitment to scientific excellence. Passionate about continuous learning and societal impact, she stands as a strong candidate for the Best Researcher Award, though further international collaborations could enhance her global academic reach.

Professional Profile

Education🎓

Dr. Iram Iqbal has pursued a progressive and research-oriented academic path in the field of pharmacology. She earned her Doctor of Pharmacy (Pharm.D.) degree in 2010 from Bahauddin Zakariya University (BZU), Multan, Pakistan, laying a solid foundation in pharmaceutical sciences. Driven by a passion for research, she completed her M.Phil. in Pharmacology from the same institution in 2015, during which she deepened her understanding of drug mechanisms and medicinal plant pharmacology. Currently, she is enrolled in a Ph.D. program in Pharmacology at BZU, where her research focuses on exploring bioactive compounds in medicinal plants and their therapeutic potentials. Her education has been marked by academic excellence, practical exposure, and a commitment to integrating traditional medicine with modern pharmacological techniques. Throughout her academic journey, Dr. Iqbal has demonstrated a consistent dedication to advancing knowledge in pharmaceutical sciences, positioning herself as a capable researcher and educator in the evolving field of pharmacology.

Professional Experience📝

Dr. Iram Iqbal has accumulated over a decade of professional experience in academia and research, primarily in the field of pharmacology. She began her career as a Lecturer in the Department of Pharmacology at the Faculty of Pharmacy, Bahauddin Zakariya University (BZU), Multan, where she has played a vital role in teaching and mentoring pharmacy students. Her professional journey is marked by a strong emphasis on research, particularly in the areas of medicinal plants, pharmacological screening, and drug safety. Dr. Iqbal has been actively involved in supervising undergraduate and postgraduate research projects, contributing to the development of new insights in pharmacology. Her work also includes collaborations on national and international research projects, participation in scientific conferences, and the publication of several research articles in peer-reviewed journals. Her blend of academic teaching and hands-on research experience has established her as a respected professional committed to advancing pharmaceutical education and therapeutic innovation.

Research Interest🔎

Dr. Iram Iqbal’s research interests lie at the intersection of pharmacology, natural product research, and drug safety. She is particularly passionate about exploring the pharmacological properties of medicinal plants and evaluating their therapeutic potential in treating various diseases. Her focus includes the isolation and characterization of bioactive compounds, understanding their mechanisms of action, and assessing their efficacy and toxicity through preclinical studies. Dr. Iqbal is also interested in the pharmacovigilance and safety profiles of both conventional and herbal medicines, aiming to ensure their safe use in clinical practice. Her work often integrates traditional knowledge with modern scientific techniques, promoting evidence-based validation of herbal remedies. She has contributed significantly to the field through her research publications, and her projects often address contemporary health challenges, such as metabolic disorders, inflammation, and infectious diseases. Through her innovative and multidisciplinary approach, Dr. Iqbal seeks to contribute to the development of safer and more effective therapeutic agents.

Award and Honor🏆

Dr. Iram Iqbal has received several awards and honors in recognition of her outstanding contributions to pharmaceutical sciences and education. Her dedication to academic excellence and impactful research has earned her prestigious accolades at both national and institutional levels. She has been honored with research appreciation certificates and excellence awards from renowned academic bodies and universities. Her scholarly work, particularly in the field of pharmacology and natural product research, has been acknowledged through best paper awards and invitations to present at esteemed scientific conferences. In addition to her research achievements, Dr. Iqbal has been recognized for her exceptional teaching and mentorship, guiding numerous students in their academic and professional journeys. Her commitment to advancing pharmaceutical education and her role in shaping future scientists and researchers have further strengthened her reputation in the academic community. These honors reflect her dedication, integrity, and impact in both research and teaching within the field of pharmacy.

Research Skill🔬

Dr. Iram Iqbal possesses a diverse and robust set of research skills that reflect her expertise in pharmaceutical sciences and pharmacology. She is proficient in designing and conducting both in vitro and in vivo experiments, particularly in the evaluation of natural products for therapeutic use. Her skills include phytochemical screening, drug formulation development, pharmacological activity assessment, and toxicity profiling. Dr. Iqbal is well-versed in utilizing advanced laboratory techniques such as chromatography, spectrophotometry, and microscopy. She also demonstrates strong capabilities in data analysis using statistical software, ensuring accurate interpretation and presentation of research findings. Her ability to conduct systematic literature reviews and synthesize existing knowledge into innovative research proposals highlights her analytical thinking. Moreover, she excels in academic writing, having authored multiple peer-reviewed publications. Her collaborative skills and experience in multidisciplinary research projects further strengthen her ability to contribute meaningfully to scientific advancements in the field of pharmaceutical and biomedical research.

Conclusion💡

Dr. Iram Iqbal possesses a robust academic foundation, diverse research contributions, technical expertise, and a strong national impact, making her highly suitable for the Best Researcher Award. While her portfolio is already compelling, strategic enhancements—particularly in international collaborations, publication strategy, and funding leadership—could further elevate her profile globally.

Publications Top Noted✍️

  • Iqbal, I., Ali, M. A. M., Saqib, F., Alamgir, K., Mubarak, M. S., Chaudhary, A. A., El-Shazly, M., & El-Nashar, H. A. S. (2025). Comprehensive GC-MS profiling and multi-modal pharmacological evaluations of Haloxylon griffithii: In vitro and in vivo approaches. Pharmaceuticals, 18(6), Article 770. https://doi.org/10.3390/ph18060770

    Citation Index: Not available yet (published May 22, 2025; newly released).

  • Iqbal, I., Wilairatana, P., Saqib, F., Nasir, B., Wahid, M., Latif, M. F., Iqbal, A., Naz, R., & Mubarak, M. S. (2023). Plant polyphenols and their potential benefits on cardiovascular health: A review. Molecules, 28(17), 6403. https://doi.org/10.3390/molecules28176403

    Citation Index: According to Crossref, this article has 9 citations as of now.

Padmanabha Rao Amarachinta | Pharmacology and Nanotechnology | Leading Innovations in Science Award

Published on by Global Scholar Awards

Prof. Padmanabha Rao Amarachinta | Pharmacology and Nanotechnology | Leading Innovations in Science Award

Professor and Deputy Registrar at Anurag University, India

Dr. Padmanabha Rao Amarachinta, Professor and Deputy Registrar at Anurag University, Hyderabad, is a distinguished scholar in pharmaceutical sciences with over 23 years of experience in teaching, research, and industry. He holds a Ph.D. in Toxicology and has conducted advanced research at premier Indian institutions like IICT, CCMB, and NIN. Dr. Rao has published over 35 high-impact papers and authored several book chapters, notably in the area of nanomedicine. His innovations in drug delivery systems, particularly intranasal delivery of Rizatriptan, have earned him both Indian and German patents. He is a recipient of numerous awards including the “Distinguished Scientist Award” and “Leading Educationist of India.” His research interests include nanotechnology, drug discovery, and clinical research, and he is actively involved in mentoring Ph.D. scholars. Dr. Rao’s impactful contributions and leadership in pharmaceutical research make him a strong candidate for the Leading Innovations in Science Award.

Professional Profile 

Education🎓

Dr. Padmanabha Rao Amarachinta possesses a strong academic background in pharmaceutical sciences, culminating in a Ph.D. in Toxicology. His educational journey laid a solid foundation for his research and teaching career, with a focus on drug delivery systems and nanomedicine. Throughout his academic training, Dr. Rao demonstrated a keen interest in toxicology and pharmacology, which guided his doctoral research and subsequent scientific contributions. His advanced studies were complemented by research collaborations with prestigious Indian institutes such as the Indian Institute of Chemical Technology (IICT), Centre for Cellular and Molecular Biology (CCMB), and the National Institute of Nutrition (NIN), where he further deepened his expertise in biomedical sciences. His academic achievements reflect a rigorous and interdisciplinary approach to science, combining theoretical knowledge with practical research applications. Dr. Rao’s educational foundation continues to influence his innovative work in pharmaceutical technology, toxicology, and clinical research, enabling him to mentor scholars and contribute to cutting-edge scientific advancements.

Professional Experience📝

Dr. Padmanabha Rao Amarachinta brings over 17 years of diverse professional experience in academia and research, specializing in pharmaceutical sciences and toxicology. He has held significant academic positions, notably serving as an Associate Professor in the Department of Pharmacy at GITAM Deemed to be University. Dr. Rao has been instrumental in designing and delivering advanced curricula in pharmacology and toxicology, mentoring postgraduate and Ph.D. scholars, and fostering a research-driven academic environment. His professional journey includes collaborative research projects with prestigious institutions such as the Indian Institute of Chemical Technology (IICT), Centre for Cellular and Molecular Biology (CCMB), and National Institute of Nutrition (NIN). He has contributed to numerous national and international journals, reflecting his strong research acumen. Dr. Rao’s career highlights his commitment to academic excellence, interdisciplinary research, and innovation in drug delivery systems, making him a respected figure in both academic and scientific communities.

Research Interest🔎

Dr. Padmanabha Rao Amarachinta’s research interests lie primarily in the fields of pharmacology, toxicology, and drug delivery systems, with a special focus on the evaluation of herbal and synthetic drugs for their therapeutic efficacy and safety. He is particularly interested in the pharmacodynamic and pharmacokinetic profiling of novel drug candidates, including natural products with potential pharmacological activity. Dr. Rao explores innovative drug delivery mechanisms to enhance the bioavailability and targeted action of therapeutic agents, aiming to reduce side effects and improve patient outcomes. His research also delves into preclinical toxicological evaluations and the mechanisms of drug-induced organ toxicity. He is passionate about bridging traditional medicinal knowledge with modern pharmacological approaches through scientific validation of herbal formulations. With collaborations across premier research institutions, his work contributes significantly to advancements in evidence-based medicine and the development of safer, more effective treatment options for chronic and acute conditions.

Award and Honor🏆

Dr. Padmanabha Rao Amarachinta has received numerous awards and honors in recognition of his outstanding contributions to pharmaceutical sciences and academic excellence. He has been honored with prestigious fellowships and accolades from reputed institutions, highlighting his dedication to research and innovation in pharmacology and toxicology. Among his notable recognitions are awards for best research paper presentations at national and international conferences, acknowledging the scientific impact and quality of his work. He has also received institutional awards for his commitment to teaching and mentoring students, fostering a collaborative and intellectually stimulating academic environment. His contributions to the field have earned him invitations to serve as a keynote speaker and session chair at several scientific events. These honors reflect not only his professional achievements but also his influence in shaping the next generation of researchers and healthcare professionals, reinforcing his status as a respected figure in the pharmaceutical and biomedical research community.

Research Skill🔬

Dr. Padmanabha Rao Amarachinta possesses a comprehensive set of research skills that span across pharmaceutical sciences, pharmacology, and toxicology. His expertise lies in experimental design, data analysis, and interpretation, particularly in preclinical and in vitro models used for drug evaluation and safety profiling. He is highly skilled in molecular biology techniques, including PCR, ELISA, and Western blotting, which he employs in elucidating mechanisms of drug action and toxicity. Dr. Amarachinta is adept at handling laboratory instruments and software for statistical and bioinformatics analysis, facilitating accurate and reproducible research outcomes. His ability to draft scientific manuscripts, research proposals, and grant applications showcases his proficiency in academic writing and communication. Additionally, he has guided numerous postgraduate students, demonstrating his capability in mentoring and collaborative research. His methodical approach, critical thinking, and problem-solving abilities significantly contribute to his success in advancing pharmaceutical research and generating impactful scientific knowledge.

Conclusion💡

Dr. Padmanabha Rao Amarachinta exhibits strong qualifications for the Leading Innovations in Science Award. His deep-rooted contributions in nanomedicine, high-impact publications, international patents, and academic leadership make him a compelling nominee. He is a proven innovator in pharmaceutical sciences with an impressive blend of academic, research, and administrative excellence.

With minor emphasis on commercialization, global project leadership, and science communication, his already remarkable portfolio could be elevated to even greater heights.

Publications Top Noted✍️

  • Title: Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effect
    Authors: PR Amarachinta, G Sharma, N Samed, AK Chettupalli, M Alle, JC Kim
    Year: 2021
    Citations: 77

  • Title: Design, formulation, in-vitro and ex-vivo evaluation of atazanavir loaded cubosomal gel
    Authors: AK Chettupalli, M Ananthula, PR Amarachinta, V Bakshi, VK Yata
    Year: 2021
    Citations: 51

  • Title: Pharmacological evaluation of herbal extracts for their in-vitro hypoglycemic activity
    Authors: AP Rao, KJ Kaiser Jamil
    Year: 2011
    Citations: 32

  • Title: Comparative toxicity of tetra ethyl lead and lead oxide to earthworms, Eisenia fetida (Savigny)
    Authors: JV Rao, P Kavitha, AP Rao
    Year: 2003
    Citations: 24

  • Title: Design, development and optimization of solid lipid nanoparticles of rizatriptan for intranasal delivery: in-vitro & in-vivo assessment
    Authors: V Bakshi, PR Amarachinta, AK Chettupalli
    Year: 2022
    Citations: 23

  • Title: Nanostructured lipid carriers to enhance the bioavailability and solubility of ranolazine: Statistical optimization and pharmacological evaluations
    Authors: A Unnisa, AK Chettupalli, RS Alazragi, W Alelwani, AM Bannunah, …
    Year: 2023
    Citations: 17

  • Title: Development and validation of glibenclamide in nanoemulsion formulation by using RP-HPLC
    Authors: AB Mohd, P Swathimutyam, AP Rao, N Shastri, PV Diwan
    Year: 2011
    Citations: 15

  • Title: Method development and validation for estimation of risperidone in novel liquisolid formulation by RP-HPLC
    Authors: K Sanka, S Bairi, R Gullapelli, S Bandi, AM Babu, AP Rao, PV Divana
    Year: 2014
    Citations: 9

  • Title: Formulation and evaluation of poly herbal liqui-solid compact for its anti-inflammatory effect
    Authors: AK Chettupalli, RR Amara, PR Amarachinta, RM Manda, BSR Garige, …
    Year: 2021
    Citations: 8

  • Title: Development and validation of simvastatin in microemulsion formulation using RP-HPLC
    Authors: C Srinivas, AB Mohd, S Huidrom, A Rao, PV Diwan
    Year: 2012
    Citations: 8

  • Title: Quality by Design approach for preparation, characterization, and statistical optimization of naproxen sodium-loaded ethosomes via transdermal route
    Authors: AK Chettupalli, S Ajmera, PR Amarachinta, RM Manda, RK Jadi
    Year: 2023
    Citations: 6

  • Title: Preclinical evaluation of polyherbal formulations: hypoglycemic activity in rats
    Authors: PR Amarachinta, KJ Kaiser Jamil
    Year: 2012
    Citations: 6

  • Title: Letter to Editor: Recent Advancement in Blood Cancer Research and Management
    Authors: MA Jahangir, AP Rao
    Year: 2019
    Citations: 4

Mohsen Mehrabi | Pharmacology | Excellence in Academic-Industry Collaboration Award

Published on by Global Scholar Awards

Assist. Prof. Dr.Mohsen Mehrabi | Pharmacology | Excellence in Academic-Industry Collaboration Award

Assistant Professor of Medical Nanotechnology at Shahroud University of Medical Sciences, Iran

Dr. Mohsen Mehrabi is an Assistant Professor of Medical Nanotechnology at Shahroud University of Medical Sciences, with a Ph.D. in Medical Nanotechnology from Tehran University of Medical Sciences. His research focuses on drug and vaccine delivery systems, nanoparticles for wound healing, and nanofiber-based wound dressings. He has published extensively in high-impact journals, contributing significantly to biomedical advancements, particularly in chitosan-based vaccine delivery, essential oil nanoemulsions, and cancer therapies. With expertise in polymeric nanoparticles, niosomes, and phytosomes, his work bridges fundamental research and practical medical applications. Additionally, he holds an MBA in Strategic Management, enhancing his ability to lead interdisciplinary projects. Despite his strong academic record, increased international collaborations, patents, and industry partnerships could further amplify his impact. Dr. Mehrabi’s dedication to innovation in nanomedicine and consistent research output make him a strong candidate for the Best Researcher Award, recognizing his contributions to advancing medical sciences

Professional Profile 

Education

Dr. Mohsen Mehrabi has a diverse and multidisciplinary educational background in medical sciences and nanotechnology. He earned his Ph.D. in Medical Nanotechnology from the School of Advanced Medical Technology at Tehran University of Medical Sciences (2012-2018), where he specialized in nanoparticle-based vaccine delivery systems. Prior to that, he completed his M.Sc. in Medical Nanotechnology at the same institution (2008-2011), focusing on chitosan nanoparticles for drug delivery. He also pursued an MBA in Strategic Management at Tehran University (2021-2022), enhancing his expertise in research leadership and project management. His undergraduate education includes a B.Sc. in Medical Laboratory Sciences from Jondi Shapour Medical University of Ahvaz (2005-2007) and an Associate Degree in Medical Laboratory Sciences from Shiraz University of Medical Sciences (2001-2003). His strong academic foundation in nanomedicine, biotechnology, and medical sciences has significantly contributed to his research in drug delivery, vaccine development, and biomedical applications.

Professional Experience

Dr. Mohsen Mehrabi is an Assistant Professor of Medical Nanotechnology at the School of Medicine, Shahroud University of Medical Sciences (2018–present). With expertise in nanomedicine, drug delivery systems, and biomedical applications, he has played a key role in advancing research on nanoparticle-based drug and vaccine delivery, wound healing, and cancer therapies. His professional journey includes extensive academic research, supervision of scientific projects, and collaboration with international experts in the field of nanotechnology. His work on polymeric nanoparticles, niosomes, phytosomes, and hydrogel-based wound dressings has led to multiple high-impact publications. Additionally, his MBA in Strategic Management has equipped him with leadership and project management skills, allowing him to contribute to research strategy and innovation. Dr. Mehrabi’s dedication to interdisciplinary research and translational science has positioned him as a leading figure in medical nanotechnology, making significant contributions to both academic and applied biomedical research.

Research Interest

Dr. Mohsen Mehrabi’s research interests focus on nanotechnology-driven solutions for drug and vaccine delivery, wound healing, and biomedical applications. His work primarily explores polymeric nanoparticles (chitosan and alginate), niosomes, and phytosomes for targeted drug and vaccine delivery systems, aiming to enhance therapeutic efficacy and immunogenicity. He is particularly interested in the development of nanoparticle-based vaccine carriers, including chitosan-loaded recombinant hepatitis B antigen, to improve immune response. His research extends to essential oil nanoemulsions for antimicrobial and therapeutic applications in both human and veterinary medicine. Additionally, he investigates hydrogel-based nanoparticles for wound healing and nanofiber mesh as advanced wound dressings. His interdisciplinary approach integrates nanomedicine, biotechnology, and pharmaceutical sciences to develop innovative and efficient drug delivery systems. Through his work, Dr. Mehrabi aims to bridge the gap between fundamental nanoscience and clinical applications, contributing to advancements in precision medicine and targeted therapies.

Award and Honor

There is no specific information provided about awards and honors received by Dr. Mohsen Mehrabi. However, given his significant contributions to the field of medical nanotechnology, his extensive research on drug and vaccine delivery systems, and his numerous high-impact publications, he is a strong candidate for academic recognition and prestigious research awards. His work on chitosan-based nanoparticles, essential oil nanoemulsions, and hydrogel-based wound dressings has advanced biomedical applications, making a notable impact in nanomedicine and biotechnology. Additionally, his leadership in interdisciplinary research and his role as an Assistant Professor at Shahroud University of Medical Sciences further highlight his academic excellence. While specific accolades are not listed, his dedication, innovation, and contributions to medical sciences make him a potential recipient of awards recognizing excellence in nanotechnology, drug delivery, and vaccine research. Further details on awards and honors could strengthen his professional profile.

Research Skill

Dr. Mohsen Mehrabi possesses advanced research skills in medical nanotechnology, drug delivery systems, and biomedical applications. His expertise includes the design, synthesis, and characterization of polymeric nanoparticles such as chitosan, alginate, niosomes, and phytosomes for targeted drug and vaccine delivery. He has extensive experience in nanoparticle formulation, stability assessment, and in vitro/in vivo evaluation of drug-loaded systems. His skills extend to hydrogel-based wound dressings, nanofiber mesh fabrication, and essential oil nanoemulsions for therapeutic applications. He is proficient in physicochemical characterization techniques, including spectroscopy, electron microscopy, and chromatographic methods, to analyze nanoparticle properties and drug release profiles. His ability to integrate nanotechnology, immunology, and pharmaceutical sciences enables him to develop novel therapeutic strategies. Additionally, his strategic research planning and project management skills, supported by his MBA in Strategic Management, enhance his ability to lead interdisciplinary studies and contribute to cutting-edge innovations in nanomedicine.

Conclusion

Dr. Mohsen Mehrabi has a remarkable research record in nanomedicine and drug delivery, making him a strong contender for the Best Researcher Award. His work has significant scientific merit, real-world medical applications, and global relevance. Strengthening industry collaborations, patenting innovations, and increasing international leadership roles could further solidify his candidacy.

Publications Top Noted

  1. Title: Comparison of the protective effects of CS/TPP and CS/HPMCP nanoparticles containing berberine in ethanol-induced hepatotoxicity in rat

    • Authors: Mahboubi Kancha M., Alizadeh M., Mehrabi M.
    • Year: 2024
    • Citation: 2

  2. Title: Isolation and Characterization of Extracellular Vesicles of Chick Embryo Blood

    • Authors: Rezakhania L., Gharibshahian M., Zamani S., Mehrabi M., Alizadeh M.
    • Year: 2024
    • Citation: 1

 

 

You said:
Craft compelling and forward-looking web content for the ‘Pharmacology’ Begin with a very short introduction and very short

Iwona Golonka | Pharmacology | Women Researcher Award

Published on by Global Scholar Awards

Dr. Iwona Golonka | Pharmacology | Best Researcher Award

Assistant Professor at Department of Physical Chemistry and Biophysics Pharmaceutical Faculty Wroclaw Medical University, Poland 

Dr. Iwona Golonka, an assistant professor at Wroclaw Medical University, is a distinguished researcher specializing in physical chemistry and pharmaceutical sciences. Over a career spanning more than two decades, she has made significant contributions to interdisciplinary research, blending theoretical chemistry with practical applications in drug development and antimicrobial therapies. She has authored 15 scientific papers with a cumulative impact factor of 48.378, including high-impact work published in top journals. Dr. Golonka’s innovative achievements include patents for novel pharmaceutical compositions, such as flotation tablets with enhanced drug delivery properties. She has collaborated with leading institutions in Poland and abroad, gaining expertise in techniques like DSC, HPLC, and chemometric methods. As a mentor and educator, she has guided numerous master’s theses and contributed to academic materials for pharmacy students. Recognized through prestigious awards and distinctions, Dr. Golonka exemplifies dedication to advancing science, education, and innovation in pharmaceutical research.

Professional Profile

Education

Dr. Iwona Golonka’s educational journey is rooted in a strong foundation in chemistry, beginning with her Master’s degree in Environmental Chemistry from the University of Wrocław in 1999. Her studies focused on understanding environmental systems through the lens of chemistry, setting the stage for her multidisciplinary approach to research. Following her Master’s, Dr. Golonka pursued full-time doctoral studies in inorganic chemistry at the same university, specializing in coordination chemistry within the Electron Paramagnetic Resonance (EPR) Group. She earned her Ph.D. in Chemical Sciences in 2006, where her research emphasized the intricate interactions of coordination compounds. Throughout her academic development, Dr. Golonka further honed her skills through research internships, such as a Socrates/Erasmus program at the University of Helsinki, where she investigated radical reaction kinetics in atmospheric conditions. Her diverse and rigorous educational background has enabled her to merge theoretical knowledge with practical applications, significantly contributing to pharmaceutical and physical chemistry.

Professional Experience

Dr. Iwona Golonka has been an assistant professor at Wroclaw Medical University since 2003, where she contributes to both research and education within the Faculty of Pharmacy’s Department of Physical Chemistry and Biophysics. Her professional experience spans various interdisciplinary research areas, with a particular focus on pharmaceutical sciences and biophysical techniques. Dr. Golonka has led and contributed to numerous collaborative research projects, exploring topics such as antimicrobial peptides, drug stability, and innovative drug delivery systems. She has developed expertise in analytical techniques like DSC, HPLC, and chemometric methods through research stays at institutions such as the Medical University of Gdańsk and Poznań University of Technology. Additionally, she has played a key role in mentoring students, guiding several master’s theses and contributing to the development of academic materials. Her involvement in numerous national and international collaborations highlights her ability to bridge theory and practice in cutting-edge pharmaceutical research.

Research Interests

Dr. Iwona Golonka’s research interests lie at the intersection of physical chemistry and pharmaceutical sciences. She focuses on understanding the molecular interactions and physicochemical properties of substances, particularly in the context of drug development and delivery. A key area of her research involves the stability and formulation of active pharmaceutical ingredients (APIs), where she employs advanced techniques such as Differential Scanning Calorimetry (DSC) and High-Performance Liquid Chromatography (HPLC). Dr. Golonka has a particular interest in antimicrobial peptides and their potential applications in treating conditions like acne vulgaris. She explores how these peptides interact with bacterial cellulose carriers to enhance their therapeutic effectiveness. Additionally, her research delves into the development of novel drug delivery systems, such as flotation tablets that provide prolonged therapeutic effects on the gastric mucosa. Through her work, Dr. Golonka combines theoretical knowledge with practical innovations, aiming to improve drug formulations and address pharmaceutical challenges.

Awards and Honors

Dr. Iwona Golonka has received numerous awards and honors in recognition of her outstanding contributions to research and innovation. In 2022, she was awarded the Rector’s Diploma from the Medical University of Gdańsk for her scientific and team achievements, specifically for her work on antimicrobial compounds and fluorescent dyes. She has also been recognized with multiple Individual II-degree Awards for her impactful publications in the JCR database in 2020, 2021, and 2022. Dr. Golonka received the prestigious 1st-degree Team Award in 2016 for her series of works on the application of physicochemical methods in drug development research. That same year, her team won a distinction in the national Eureka! MZD competition for inventing a flotation tablet with prolonged interaction with the gastric mucosa. Additionally, she has received several other team awards, scholarships, and distinctions, underscoring her commitment to advancing science and innovation in pharmaceutical and chemical research.

Conclusion

Dr. Iwona Golonka is a strong candidate for the Women Researcher Award due to her extensive research contributions, interdisciplinary focus, and innovative achievements in pharmaceutical sciences. Her work demonstrates a blend of academic rigor, practical innovation, and collaborative success. However, to further strengthen her profile, efforts to lead independent research initiatives, secure funding, and expand high-impact publications would be beneficial. Overall, her academic and professional accomplishments make her a deserving candidate for the recognition.

Publications Top Noted

  • The Influence of the Amphiphilic Properties of Peptides on the Phosphatidylinositol Monolayer in the Presence of Ascorbic Acid
    Authors: Iwona Golonka, Izabela W. Łukasiewicz, Aleksandra Sebastiańczyk, Katarzyna E. Greber, Wiesław Sawicki, Witold Musiał
    Year: 2024
    Citation: 10.3390/ijms252312484
  • Evaluation of Decay Kinetics of Black Elderberry Antioxidants from Fruits and Flowers
    Authors: Iwona Golonka, Andrzej Dryś, Katarzyna Podgórska, Joanna Polewska, Witold Musiał
    Year: 2024
    Citation: 10.3390/antiox13070804
  • Antioxidants in Cellulose Matrices
    Authors: Iwona Golonka, Katarzyna Podgórska, Joanna Polewska, Witold Musiał
    Year: 2023
    Citation: UMW3f70b0de4525427ea6cabe0e010abb69
  • Oddziaływanie peptydu (C12)2-KKKK-NH2 Z monowarstwą fosfatydyloinozytolu
    Authors: Iwona Golonka, Izabela W. Łukasiewicz, Katarzyna E. Greber, Witold Musiał
    Year: 2023
    Citation: UMW1bb9af4b111a4a48a092679bd4172a3c
  • Evaluation of the Effect of Antibacterial Peptides on Model Monolayers
    Authors: Iwona Golonka, Jakub E. Pucułek, Katarzyna E. Greber, Andrzej Dryś, Wiesław Sawicki, Witold Musiał
    Year: 2023
    Citation: 10.3390/ijms241914861
  • Effect of Newly Synthesized Structures of Peptides on the Stability of the Monolayers Formed
    Authors: Iwona Golonka, Katarzyna E. Greber, Bartłomiej M. Szyja, Patrycja P. Petrus, Jakub E. Pucułek, Witold Musiał
    Year: 2023
    Citation: 10.3390/ijms24054318
  • Effect of Structures of Newly Synthesized Peptides on the Stability of the Formed Monolayers
    Authors: Iwona Golonka, Patrycja P. Petrus, Jakub E. Pucułek, Katarzyna E. Greber, Witold Musiał
    Year: 2022
    Citation: UMW082a9a8f211041978645eb253f6df04d
  • Evaluation of the Monolayer Properties of the Model Cell Membrane Produced with Antibacterial Peptides
    Authors: Iwona Golonka, Jakub E. Pucułek, Patrycja P. Petrus, Katarzyna E. Greber, Witold Musiał
    Year: 2022
    Citation: UMWdf46a4a6ae084c1cae3989d5f012c9b2
  • Selected Applications of Langmuir Balance in Pharmaceutical Sciences
    Authors: Witold Musiał, Iwona Golonka, Remigiusz Zapolski
    Year: 2022
    Citation: UMW36636ce3606a47f4a4d27a4446b9138f
  • Assessment of the Influence of the Selected Range of Visible Light Radiation on the Durability of the Gel with Ascorbic Acid and Its Derivative
    Authors: Iwona Golonka, Beata Kizior, Bartłomiej M. Szyja, Mateusz P. Damek, Witold Musiał
    Year: 2022
    Citation: 10.3390/ijms23158759
  • Ocena wpływu wybranego zakresu promieniowania światła widzialnego na trwałość preparatów hydrożelowych zawierających kwas askorbinowy i jego pochodną
    Authors: Iwona Golonka, Mateusz P. Damek, Witold Musiał
    Year: 2021
    Citation: UMW79553fcc4532460cbd473a7975eaea2a
  • Antimicrobial and Antioxidative Activity of Newly Synthesized Peptides Absorbed into Bacterial Cellulose Carrier Against Acne Vulgaris
    Authors: Iwona Golonka, Katarzyna E. Greber, Monika Oleksy-Wawrzyniak, Justyna Paleczny, Andrzej Dryś, Adam Junka, Wiesław Sawicki, Witold Musiał
    Year: 2021
    Citation: 10.3390/ijms22147466
  • Edible Alginate/Chitosan-Based Nanocomposite Microspheres as Delivery Vehicles of Omega-3 Rich Oils
    Authors: Said F. Hamed, Ayat F. Hashim, Hoda A. Abdel Hamid, Kamel A. Abd-Elsalam, Iwona Golonka, Witold Musiał, Ibrahim M. El-Sherbiny
    Year: 2020
    Citation: 10.1016/j.carbpol.2020.116201
  • The Influence of UV Radiation on the Degradation of Pharmaceutical Formulations Containing Quercetin
    Authors: Iwona Golonka, Stanisław Wilk, Witold Musiał
    Year: 2020
    Citation: 10.3390/molecules25225454
  • Antioxidant and Antibacterial Activities of Omega-3 Rich Oils/Curcumin Nanoemulsions Loaded in Chitosan and Alginate-Based Microbeads
    Authors: Ayat F. Hashim, Said F. Hamed, Hoda A. Abdel Hamid, Kamel A. Abd-Elsalam, Iwona Golonka, Witold Musiał, Ibrahim M. El-Sherbiny
    Year: 2019
    Citation: 10.1016/j.ijbiomac.2019.08.085